Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Statins may slow prostate cancer progression
(May 18, 2015 - Insidermedicine) From Boston - Statins may ...
(May 18, 2015 - Insidermedicine) From Boston - Statins may help slow prostate cancer progression, according to a report published in JAMA Oncology. Researchers studied nearly 1,000 prostate cancer patients undergoing androgen deprivation therapy. Results showed that those who had been taking statins since starting the therapy went a median of 27.5 months before their cancer worsened, while those who had not been taking statins went 17.4 months before the disease progressed
-
HD
Treating diabetic macular edema (DME) with ranibizumab
(May 15, 2015 - Insidermedicine) From Pennsylvania - Research published ...
(May 15, 2015 - Insidermedicine) From Pennsylvania - Research published in Ophthalmology examines the cost-effectiveness of treating diabetic macular edema with ranibizumab. Researchers reviewed data from the RISE and RIDE clinical trials. They performed cost-utility analysis associated with intravitreal ranibizumab vs. sham therapy for diabetic macular edema. Researchers measured quality-adjusted life years (QALY) in patients as well the cost-utility ratio, measured as $/QALY. Results showed that 14 year incremental patient value gain resulting from the treatment equated to an 11% improvement in quality of life. After accounting for direct medical costs that were saved from the treatment, researchers found that use of this therapy conferred significant gain to the patient and resulted in a financial value gain.
-
HD
Reducing C Difficile Infections
(May 14, 2015 - Insidermedicine) From Chicago - Oral administration ...
(May 14, 2015 - Insidermedicine) From Chicago - Oral administration of harmless C difficile spores can reduce recurrence of the infection, according to a report published in JAMA. Researchers studied 173 patients who were diagnosed with CDI. Participants were randomly assigned to receive 1 of 4 treatments—three of which contained liquid formulation of nontoxigenic C difficile spores, and one placebo. CDI recurrence was 30% among those taking placebo but only 11% among those taking the spores.
-
HD
New Treatment for Hepatitis C
(May 13, 2015 - Insidermedicine) From North Carolina - A ...
(May 13, 2015 - Insidermedicine) From North Carolina - A new report published in JAMA finds a novel treatment that can clear hepatitis C infection in liver cirrhosis patients. Researchers studied over 200 liver cirrhosis patients, over 100 of whom had not yet been treated for hepatitis C, and 90 who had been treated unsuccessfully. Participants underwent 12 weeks of an investigational three drug combination. The combo cleared the virus in 93% of patients who had not yet been treated, while adding a fourth drug to the combo also cleared the virus in 93% of those who had been previously treated
-
HD
New screening method may pick up twice as many ovarian cancers
(May 12, 2015 - Insidermedicine) From the UK - A ...
(May 12, 2015 - Insidermedicine) From the UK - A novel screening method for ovarian cancer may pick up twice as many cancers, according to a report published in the Journal of Clinical Oncology. Researchers studied over 46,000 women, randomly assigning participants to transvaginal ultrasound or multi-modal screening. The latter is a new technique in which statistical calculation is used to exactly interpret changing levels of a particular protein linked to ovarian cancer may affect their risk of developing the disease. Results showed that the new method detected cancer in 86% of women with invasive epithelial ovarian cancer, whereas conventional test identifies half that many.
-
HD
Report examines concussions in youth and college football games
(May 11, 2015 - Insidermedicine) From Indianapolis - Research published ...
(May 11, 2015 - Insidermedicine) From Indianapolis - Research published in JAMA Pediatrics examines the incidence of concussions during youth and college football games. Researchers studied 118 youth football teams, 96 secondary school teams and 24 college teams. They found that 53.9% of concussions during youth football occurred during games, however, most concussions during college and high school football occurred in practice. There were no concussions for youth aged 5-7 years.
-
HD
AIDS patients at higher risk of AMD
(May 11, 2015 - Insidermedicine) From New York - A ...
(May 11, 2015 - Insidermedicine) From New York - A new report published in the American Journal of Ophthalmology finds that patients AIDS are are heightened risk of age-related macular degeneration. Researchers studied nearly 2,000 AIDS patients between the ages of 13-73 years. Researchers reviewed retinal photographs and compared these participants to non-HIV infected individuals from a long term study. They found that prevalence of AMD among the AIDS patients was approximately 4x greater than those without the disease.
-
HD
Inattention linked to lower academic scores
(May 5, 2015 - Insidermedicine) From the UK - Inattention ...
(May 5, 2015 - Insidermedicine) From the UK - Inattention at age seven may be linked to lower academic performance in adolescence, according to a new report in the Journal of the American Academy of Child and Adolescent Psychiatry. Parents and teachers completed questionnaires on inattention and hyperactivity for over 11,000 seven year old children. Higher inattention scores on this questionnaire were linked to lower scores on standardized tests at age 16.
-
HD
Distraction with a mobile device may reduce pain during minor surgery
(May 4, 2015 - Insidermedicine) From New York - Using ...
(May 4, 2015 - Insidermedicine) From New York - Using a mobile device during a minor surgery with a local anesthetic may help to reduce perceived pain, according to a report publish in the journal Pain Medicine. Participants were broken in to 4 groups, each with a different task to perform during a minor surgical procedure: playing a mobile game, texting with a companion, texting with a stranger, and a control group not using a mobile device. Those receiving standard care were over 6 times more likely to receive supplemental pain relief than those texting with a stranger, 4 times more likely than those texting with a friend or family member, and nearly twice as likely than those playing the mobile game.
-
HD
Sweetened beverages increase the risk of diabetes
(May 4, 2015 - Insidermedicine) From the UK - Both ...
(May 4, 2015 - Insidermedicine) From the UK - Both artificial and sugar sweetened beverages may increase the risk of developing type 2 diabetes, according to a new report in Diabetologia. With the help of over 25,000 people who were followed for 11 years, researchers found a 22% increased risk of developing type 2 diabetes for each extra serving of soft drinks, sweetened milk beverages, and artificially-sweetened beverages.
